Healthcare provider profile · identity verified

Mitchell D Krathwohl, MD

Infectious Disease · INDIANAPOLIS, IN · NPI 1447225818

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	365	114
Amlodipine Besylate	Amlodipine Besylate	228	70
Lisinopril	Lisinopril	176	51
Gabapentin	Gabapentin	151	36
Losartan Potassium	Losartan Potassium	150	47
Metformin Hcl	Metformin Hcl	141	39
Omeprazole	Omeprazole	118	37
Levothyroxine Sodium	Levothyroxine Sodium	117	39
Hydrochlorothiazide	Hydrochlorothiazide	108	35
Albuterol Sulfate Hfa	Albuterol Sulfate	81	22
Pantoprazole Sodium	Pantoprazole Sodium	78	21
Trazodone Hcl	Trazodone Hcl	76	22
Pravastatin Sodium	Pravastatin Sodium	75	22
Rosuvastatin Calcium	Rosuvastatin Calcium	65	16
Metoprolol Succinate	Metoprolol Succinate	64	25
Ozempic	Semaglutide	64	14
Mounjaro	Tirzepatide	63	14
Furosemide	Furosemide	54	17
Metformin Hcl Er	Metformin Hcl	49	17
Alendronate Sodium	Alendronate Sodium	47	11
Allopurinol	Allopurinol	47	15
Metoprolol Tartrate	Metoprolol Tartrate	47	16
Carvedilol	Carvedilol	46	13
Eliquis	Apixaban	46	suppressed
Glipizide	Glipizide	40	12
Jardiance	Empagliflozin	40	12
Tamsulosin Hcl	Tamsulosin Hcl	40	15
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Prednisone	Prednisone	38	34
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Potassium Chloride	Potassium Chloride	36	14
Spironolactone	Spironolactone	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	12
Montelukast Sodium	Montelukast Sodium	31	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Acyclovir	Acyclovir	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	19
Sertraline Hcl	Sertraline Hcl	28	11
Chlorthalidone	Chlorthalidone	27	suppressed
Simvastatin	Simvastatin	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	15
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Naproxen	Naproxen	23	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Atenolol	Atenolol	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Famotidine	Famotidine	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Kerendia	Finerenone	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Indapamide	Indapamide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Azithromycin	Azithromycin	14	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nystatin	Nystatin	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error